Catherine E. Snider

1.2k total citations
18 papers, 1.0k citations indexed

About

Catherine E. Snider is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Catherine E. Snider has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Genetics. Recurrent topics in Catherine E. Snider's work include Signaling Pathways in Disease (5 papers), Peptidase Inhibition and Analysis (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Catherine E. Snider is often cited by papers focused on Signaling Pathways in Disease (5 papers), Peptidase Inhibition and Analysis (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Catherine E. Snider collaborates with scholars based in United States. Catherine E. Snider's co-authors include Terry B. Strom, John R. Murphy, Diane P. Williams, Robert W. Brueggemeier, Geoffrey L. Greene, Neil G. Almstead, Biswanath De, Yetunde O. Taiwo, Michael G. Natchus and Stanisław Pikul and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Annals of the New York Academy of Sciences.

In The Last Decade

Catherine E. Snider

18 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine E. Snider United States 14 409 320 294 240 177 18 1.0k
Maryann B. Flick United States 18 653 1.6× 218 0.7× 119 0.4× 277 1.2× 167 0.9× 30 1.1k
Yukimasa Shiotsu Japan 22 1.1k 2.8× 235 0.7× 241 0.8× 305 1.3× 112 0.6× 47 1.8k
Gerd Nagel Germany 16 285 0.7× 191 0.6× 107 0.4× 190 0.8× 68 0.4× 34 675
Hanne Grøn United States 13 737 1.8× 96 0.3× 634 2.2× 172 0.7× 88 0.5× 16 1.2k
Hans R. Hendriks Netherlands 21 580 1.4× 259 0.8× 41 0.1× 321 1.3× 252 1.4× 49 1.3k
George H. Mickey United States 9 709 1.7× 274 0.9× 217 0.7× 377 1.6× 249 1.4× 11 1.5k
Narmada Shenoy United States 11 532 1.3× 138 0.4× 86 0.3× 240 1.0× 145 0.8× 17 990
Harold J. Brenner Israel 8 351 0.9× 80 0.3× 225 0.8× 255 1.1× 180 1.0× 15 776
Alexei Vassilev United States 21 574 1.4× 319 1.0× 91 0.3× 287 1.2× 80 0.5× 49 1.4k
Gerald Nabozny United States 23 309 0.8× 735 2.3× 231 0.8× 198 0.8× 134 0.8× 54 1.5k

Countries citing papers authored by Catherine E. Snider

Since Specialization
Citations

This map shows the geographic impact of Catherine E. Snider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine E. Snider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine E. Snider more than expected).

Fields of papers citing papers by Catherine E. Snider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine E. Snider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine E. Snider. The network helps show where Catherine E. Snider may publish in the future.

Co-authorship network of co-authors of Catherine E. Snider

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine E. Snider. A scholar is included among the top collaborators of Catherine E. Snider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine E. Snider. Catherine E. Snider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
De, Biswanath, Stanisław Pikul, Neil G. Almstead, et al.. (2000). Design and Synthesis of Piperazine-Based Matrix Metalloproteinase Inhibitors. Journal of Medicinal Chemistry. 43(3). 369–380. 83 indexed citations
2.
De, Biswanath, Michael G. Natchus, Stanisław Pikul, et al.. (1999). The Next Generation of MMP Inhibitors: Design and Synthesis. Annals of the New York Academy of Sciences. 878(1). 40–60. 28 indexed citations
3.
Natchus, Michael G., Stanisław Pikul, Neil G. Almstead, et al.. (1998). Design and synthesis of conformationally-constrained MMP inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(16). 2077–2080. 26 indexed citations
4.
Pikul, Stanisław, Neil G. Almstead, Biswanath De, et al.. (1998). Discovery of Potent, Achiral Matrix Metalloproteinase Inhibitors. Journal of Medicinal Chemistry. 41(19). 3568–3571. 69 indexed citations
5.
Pikul, Stanisław, Neil G. Almstead, Biswanath De, et al.. (1998). Design and Synthesis of Phosphinamide-Based Hydroxamic Acids as Inhibitors of Matrix Metalloproteinases. Journal of Medicinal Chemistry. 42(1). 87–94. 68 indexed citations
6.
Waters, Cory A., Catherine E. Snider, Kyogo Itoh, et al.. (1991). DAB486IL‐2 (IL‐2 Toxin) Selectively Inactivates High‐Affinity IL‐2 Receptor‐Bearing Human Peripheral Blood Mononuclear Cells. Annals of the New York Academy of Sciences. 636(1). 403–405. 19 indexed citations
7.
Kiyokawa, Tetsuyuki, Diane P. Williams, Catherine E. Snider, Terry B. Strom, & John R. Murphy. (1991). Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells. Protein Engineering Design and Selection. 4(4). 463–468. 44 indexed citations
8.
Kiyokawa, Tetsuyuki, Diane P. Williams, Catherine E. Snider, et al.. (1991). Protein Engineering of DAB‐IL‐2 Fusion Toxins to Increase Biologic Potencya. Annals of the New York Academy of Sciences. 636(1). 331–339. 6 indexed citations
9.
Waters, Cory A., Catherine E. Snider, Kyogo Itoh, et al.. (1990). Interleukin 2 receptor‐targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin‐related interleukin 2 fusion protein into cells. European Journal of Immunology. 20(4). 785–791. 95 indexed citations
10.
Williams, Diane P., Catherine E. Snider, Terry B. Strom, & John R. Murphy. (1990). Structure/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells.. Journal of Biological Chemistry. 265(20). 11885–11889. 152 indexed citations
11.
Snider, Catherine E., et al.. (1988). Ligand-Modulated Regulation of Progesterone Receptor Messenger Ribonucleic Acid and Protein in Human Breast Cancer Cell Lines. Molecular Endocrinology. 2(3). 263–271. 190 indexed citations
12.
Brueggemeier, Robert W., et al.. (1987). 7 α -Substituted androstenediones as effective in vttro and invivo inhibitors of aromatase. Steroids. 50(1-3). 163–178. 36 indexed citations
13.
Snider, Catherine E. & Robert W. Brueggemeier. (1987). Potent enzyme-activated inhibition of aromatase by a 7 alpha-substituted C19 steroid.. Journal of Biological Chemistry. 262(18). 8685–8689. 48 indexed citations
14.
Snider, Catherine E. & Robert W. Brueggemeier. (1985). Covalent modification of aromatase by a radiolabeled irreversible inhibitor. Journal of Steroid Biochemistry. 22(3). 325–330. 18 indexed citations
15.
Brueggemeier, Robert W., et al.. (1982). A photoaffinity inhibitor of aromatase. Steroids. 40(6). 679–689. 11 indexed citations
16.
Brueggemeier, Robert W., Catherine E. Snider, & Raymond E. Counsell. (1982). Substituted C19 steroid analogs as inhibitors of aromatase.. PubMed. 42(8 Suppl). 3334s–3337s. 11 indexed citations
17.
Olson, K. C., et al.. (1981). Purified human growth hormone from E. coli is biologically active. Nature. 293(5831). 408–411. 105 indexed citations
18.
Yuan, Pau M., et al.. (1979). A deletion mutation in glucosephosphate isomerase (GPI denton). Clinica Chimica Acta. 92(3). 481–489. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maryann B. Flick Breakdown of academic impact, for papers by Yukimasa Shiotsu Breakdown of academic impact, for papers by Gerd Nagel Breakdown of academic impact, for papers by Hanne Grøn Breakdown of academic impact, for papers by Hans R. Hendriks Breakdown of academic impact, for papers by George H. Mickey Breakdown of academic impact, for papers by Narmada Shenoy Breakdown of academic impact, for papers by Harold J. Brenner Breakdown of academic impact, for papers by Alexei Vassilev Breakdown of academic impact, for papers by Gerald Nabozny
Rankless by CCL
2026